scholarly article | Q13442814 |
P356 | DOI | 10.1016/J.SEMARTHRIT.2008.01.012 |
P698 | PubMed publication ID | 18336869 |
P50 | author | Javier Martin | Q55089349 |
P2093 | author name string | Carlos Gonzalez-Juanatey | |
Javier Llorca | |||
Miguel A. Gonzalez-Gay | |||
P433 | issue | 5 | |
P921 | main subject | circulatory system | Q11068 |
patient | Q181600 | ||
rheumatoid arthritis | Q187255 | ||
P304 | page(s) | 366-371 | |
P577 | publication date | 2009-04-01 | |
P1433 | published in | Seminars in Arthritis and Rheumatism | Q15761553 |
P1476 | title | Carotid Intima-Media Thickness Predicts the Development of Cardiovascular Events in Patients with Rheumatoid Arthritis | |
P478 | volume | 38 |
Q52684868 | A genetic association study of carotid intima-media thickness (CIMT) and plaque in Mexican Americans and European Americans with rheumatoid arthritis. |
Q35907814 | Advanced glycation endproducts are increased in rheumatoid arthritis patients with controlled disease |
Q50553806 | Amino-terminal pro-brain natriuretic peptide as a prognostic marker in patients with rheumatoid arthritis |
Q34450615 | Analysis of the interferon gamma (rs2430561, +874T/A) functional gene variant in relation to the presence of cardiovascular events in rheumatoid arthritis |
Q36151574 | Anti-TNF-alpha-adalimumab therapy is associated with persistent improvement of endothelial function without progression of carotid intima-media wall thickness in patients with rheumatoid arthritis refractory to conventional therapy |
Q38857820 | Anti-citrullinated peptide antibodies and their value for predicting responses to biologic agents: a review |
Q84089796 | Assessment of cardiovascular risk in rheumatoid arthritis: impact of the new EULAR recommendations on the score cardiovascular risk index |
Q41670041 | Assessment of intracranial vessels in association with carotid atherosclerosis and brain vascular lesions in rheumatoid arthritis. |
Q48548043 | Assessment of local carotid stiffness in seronegative and seropositive rheumatoid arthritis |
Q35617635 | Association of acid phosphatase locus 1*C allele with the risk of cardiovascular events in rheumatoid arthritis patients |
Q58743766 | Association of circulating calprotectin with lipid profile in axial spondyloarthritis |
Q30396421 | Associations between Carotid Artery Plaque Score, Carotid Hemodynamics and Coronary Heart Disease |
Q27010113 | Atherosclerosis in juvenile idiopathic arthritis |
Q37786648 | Atherosclerotic vascular damage and rheumatoid arthritis: a complex but intriguing link |
Q46635567 | Automated radiofrequency-based US measurement of common carotid intima-media thickness in RA patients treated with synthetic vs synthetic and biologic DMARDs. |
Q38230867 | Beyond the joint: Subclinical atherosclerosis in rheumatoid arthritis |
Q35864204 | Biomarkers of subclinical atherosclerosis in patients with autoimmune disorders |
Q36490766 | CARD8 rs2043211 (p.C10X) polymorphism is not associated with disease susceptibility or cardiovascular events in Spanish rheumatoid arthritis patients |
Q35617726 | CCR5Δ32 variant and cardiovascular disease in patients with rheumatoid arthritis: a cohort study |
Q38185646 | Can suppression of inflammation by anti-TNF prevent progression of subclinical atherosclerosis in inflammatory arthritis? |
Q38568465 | Cardiovascular comorbidity in rheumatic diseases |
Q36218375 | Cardiovascular disease and rheumatoid arthritis: an update |
Q38950371 | Cardiovascular disease in patients with rheumatoid arthritis |
Q34495257 | Cardiovascular disease in rheumatoid arthritis: a systematic literature review in latin america |
Q33766283 | Cardiovascular disease is increased prior to onset of rheumatoid arthritis but not osteoarthritis: the population-based Nord-Trøndelag health study (HUNT) |
Q37859676 | Cardiovascular disease risk in rheumatoid arthritis: progress, debate, and opportunity |
Q28082992 | Cardiovascular disease risk scores in the current practice: which to use in rheumatoid arthritis? |
Q34081242 | Cardiovascular involvement in autoimmune diseases |
Q26739070 | Cardiovascular risk assessment in patients with rheumatoid arthritis: The relevance of clinical, genetic and serological markers |
Q38090373 | Cardiovascular risk in juvenile idiopathic arthritis |
Q53101781 | Cardiovascular risk stratification in rheumatic diseases: carotid ultrasound is more sensitive than Coronary Artery Calcification Score to detect subclinical atherosclerosis in patients with rheumatoid arthritis. |
Q37796382 | Carotid Intima Media Thickness in Rheumatoid Arthritis as Compared to Control Subjects: A Meta-Analysis |
Q35222947 | Carotid artery plaque in women with rheumatoid arthritis and low estimated cardiovascular disease risk: a cross-sectional study |
Q59794786 | Carotid artery volumetric measures associate with clinical ten-year cardiovascular (CV) risk scores and individual traditional CV risk factors in rheumatoid arthritis; a carotid-MRI feasibility study |
Q35777047 | Carotid atherosclerosis predicts incident acute coronary syndromes in rheumatoid arthritis |
Q40885947 | Carotid intima-media thickness and endothelial function: useful surrogate markers for establishing cardiovascular risk in patients with inflammatory rheumatic disease |
Q45751847 | Carotid intima-media thickness and endothelial function: useful surrogate markers for establishing cardiovascular risk in patients with inflammatory rheumatic disease – authors' response. |
Q37596934 | Carotid intima-media thickness measurement in cardiovascular screening programmes |
Q37691111 | Classical cardiovascular disease risk factors associate with vascular function and morphology in rheumatoid arthritis: a six-year prospective study. |
Q43581222 | Clinical significance of brachial flow-mediated dilation in patients with rheumatoid arthritis |
Q89278102 | Comparison of statin eligibility according to the Adult Treatment Panel III, ACC/AHA blood cholesterol guideline, and presence of carotid plaque by ultrasound in Mexican mestizo patients with rheumatoid arthritis |
Q37246482 | Coronary Artery Calcification Is Related to Inflammation in Rheumatoid Arthritis: A Long-Term Follow-Up Study |
Q35557952 | Correlation between endothelial function and carotid atherosclerosis in rheumatoid arthritis patients with long-standing disease |
Q51174739 | Could cardiovascular disease risk stratification and management in rheumatoid arthritis be enhanced? |
Q41482717 | Differential Association of Psychosocial Comorbidities With Subclinical Atherosclerosis in Rheumatoid Arthritis |
Q44973053 | Effects of rosuvastatin on subclinical atherosclerosis and arterial stiffness in rheumatoid arthritis: a randomized controlled pilot trial |
Q87621947 | Epicardial adipose tissue thickness, flow-mediated dilatation of the brachial artery, and carotid intima-media thickness: Associations in rheumatoid arthritis patients |
Q36165202 | Genetic markers of cardiovascular disease in rheumatoid arthritis. |
Q91715328 | Identification of a 3'-Untranslated Genetic Variant of RARB Associated With Carotid Intima-Media Thickness in Rheumatoid Arthritis: A Genome-Wide Association Study |
Q42326308 | Implication of new atherosclerotic carotid plaques in the cardiovascular outcome of patients with rheumatoid arthritis |
Q90415124 | Important Considerations for Examining Endothelial Dysfunction in Rheumatoid Arthritis |
Q92708651 | Incidence and effect of insulin resistance on progression of atherosclerosis in rheumatoid arthritis patients of long disease duration |
Q37206972 | Inflammation predicts accelerated brachial arterial wall changes in patients with recent-onset rheumatoid arthritis. |
Q42755997 | Inflammation, endothelial function and atherosclerosis in rheumatoid arthritis |
Q44958376 | Inflammatory burden interacts with conventional cardiovascular risk factors for carotid plaque formation in rheumatoid arthritis |
Q37563513 | Influence of coronary artery disease and subclinical atherosclerosis related polymorphisms on the risk of atherosclerosis in rheumatoid arthritis. |
Q37184930 | Influence of elevated-CRP level-related polymorphisms in non-rheumatic Caucasians on the risk of subclinical atherosclerosis and cardiovascular disease in rheumatoid arthritis |
Q34485757 | Interferon regulatory factor 5 genetic variants are associated with cardiovascular disease in patients with rheumatoid arthritis |
Q36172927 | Is Lipoprotein-Associated Phospholipase A2 a Link between Inflammation and Subclinical Atherosclerosis in Rheumatoid Arthritis? |
Q35217530 | Kidney function, endothelial activation and atherosclerosis in black and white Africans with rheumatoid arthritis |
Q37699878 | Lack of association between ABO, PPAP2B, ADAMST7, PIK3CG, and EDNRA and carotid intima-media thickness, carotid plaques, and cardiovascular disease in patients with rheumatoid arthritis |
Q36081372 | Lack of association between TLR4 rs4986790 polymorphism and risk of cardiovascular disease in patients with rheumatoid arthritis |
Q57307072 | Lack of association of IL6R rs2228145 and IL6ST/gp130 rs2228044 gene polymorphisms with cardiovascular disease in patients with rheumatoid arthritis |
Q35489690 | Longitudinal predictors of progression of carotid atherosclerosis in rheumatoid arthritis |
Q26822038 | Metabolic syndrome in rheumatoid arthritis |
Q36245756 | Obesity and carotid atherosclerosis in African black and Caucasian women with established rheumatoid arthritis: a cross-sectional study |
Q34128912 | Osteoprotegerin CGA haplotype protection against cerebrovascular complications in anti-CCP negative patients with rheumatoid arthritis |
Q36245670 | Predictors of new atherosclerotic carotid plaque development in patients with rheumatoid arthritis: a longitudinal study |
Q58728255 | Prospective assessment of cardiovascular risk parameters in patients with rheumatoid arthritis |
Q35842035 | Protective Role of the Interleukin 33 rs3939286 Gene Polymorphism in the Development of Subclinical Atherosclerosis in Rheumatoid Arthritis Patients. |
Q45669904 | Relationship between inflammatory markers, oxidant-antioxidant status and intima-media thickness in prepubertal children with juvenile idiopathic arthritis |
Q50881501 | Relationship between pulse wave velocity and serum YKL-40 level in patients with early rheumatoid arthritis. |
Q36830486 | Rheumatoid arthritis impacts on the independent relationships between circulating adiponectin concentrations and cardiovascular metabolic risk |
Q37691220 | Rheumatoid arthritis is associated with reduced adiposity but not with unfavorable major cardiovascular risk factor profiles and enhanced carotid atherosclerosis in black Africans from a developing population: a cross-sectional study |
Q60592413 | Rheumatoid arthritis is sufficient to cause atheromatosis but not arterial stiffness or hypertrophy in the absence of classical cardiovascular risk factors |
Q27008359 | Role of adipokines in atherosclerosis: interferences with cardiovascular complications in rheumatic diseases |
Q42640261 | Role of carotid ultrasonography in the evaluation of cardiovascular risk in patients with rheumatoid arthritis |
Q37691093 | SCORE and REGICOR function charts underestimate the cardiovascular risk in Spanish patients with rheumatoid arthritis |
Q35035496 | SMAD3 rs17228212 gene polymorphism is associated with reduced risk to cerebrovascular accidents and subclinical atherosclerosis in anti-CCP negative Spanish rheumatoid arthritis patients. |
Q37294162 | Serum Resistin Level and Progression of Atherosclerosis during Glucocorticoid Therapy for Systemic Autoimmune Diseases |
Q34697924 | Serum amyloid A as a marker of persistent inflammation and an indicator of cardiovascular and renal involvement in patients with rheumatoid arthritis |
Q35257568 | Significant effects of biologic therapy on lipid profiles and insulin resistance in patients with rheumatoid arthritis |
Q43407682 | Single-nucleotide polymorphisms at the 9p21.3 genomic region not associated with the risk of cardiovascular disease in patients with rheumatoid arthritis |
Q58767097 | Spectral Doppler and automated software-guided ultrasound assessment of bilateral common carotid intima-media thickness in spondyloarthritis: is there a correlation with clinical findings? |
Q34482096 | Study of association of CD40-CD154 gene polymorphisms with disease susceptibility and cardiovascular risk in Spanish rheumatoid arthritis patients. |
Q34590834 | Subclinical atherosclerosis in patients with rheumatoid arthritis by utilizing carotid intima-media thickness as a surrogate marker. |
Q34550743 | Systemic inflammation and cardiovascular risk factors predict rapid progression of atherosclerosis in rheumatoid arthritis |
Q38519523 | Targeting inflammation in the prevention of cardiovascular disease in patients with inflammatory arthritis. |
Q46174533 | The 11q23.3 genomic region-rs964184-is associated with cardiovascular disease in patients with rheumatoid arthritis. |
Q41211836 | The 2013 ACC/AHA 10-year atherosclerotic cardiovascular disease risk index is better than SCORE and QRisk II in rheumatoid arthritis: is it enough? |
Q34388576 | The ZC3HC1 rs11556924 polymorphism is associated with increased carotid intima-media thickness in patients with rheumatoid arthritis |
Q35204645 | The ability of the 2013 American College of Cardiology/American Heart Association cardiovascular risk score to identify rheumatoid arthritis patients with high coronary artery calcification scores |
Q33938590 | The association between microvascular and macrovascular endothelial function in patients with rheumatoid arthritis: a cross-sectional study. |
Q33584053 | The relationship between race, cigarette smoking and carotid intimal medial thickness in systemic lupus erythematosus |
Q34272487 | The role of inflammation and cardiovascular disease risk on microvascular and macrovascular endothelial function in patients with rheumatoid arthritis: a cross-sectional and longitudinal study |
Q37533298 | Towards improving cardiovascular risk management in patients with rheumatoid arthritis: the need for accurate risk assessment |
Q46468090 | Tumour necrosis factor blocking agents and progression of subclinical atherosclerosis in patients with ankylosing spondylitis |
Q34164481 | Validated methods for assessment of subclinical atherosclerosis in rheumatology |
Q53827279 | Variables associated with subclinical atherosclerosis in a cohort of rheumatoid arthritis patients: Sex-specific associations and differential effects of disease activity and age. |
Q64640827 | Cardiovascular Disease Biomarkers in Smokers and Moist Snuff Consumers |
Q66393513 | Carotid Intima-media Thickness as Cardiovascular Mortality Predictor in Peritoneal Dialysis Patients |
Q64806423 | Dapagliflozin, Cardio-Metabolic Risk Factors and Type-2 Diabetes |
Q63818033 | Effect of NCX4016 on Walking Distance in Patients With Peripheral Arterial Occlusive Disease (PAOD) |
Q64046848 | Effectiveness of Growth Hormone Releasing Hormone in Reducing Abdominal Fat in People Who Are Obese |
Q65333041 | Efficacy and Safety of Simvastatin-ezetimibe Combination Therapy Among Patients With SLE |
Q65347197 | High-Intensity Aerobic Interval Training in Testicular Cancer Survivors |
Q64397455 | Low-dose Colchicine in Patients With Type 2 Diabetes Mellitus and Microalbuminuria |
Q65538279 | Multiple Interventions Related to Dialysis Procedures in Order to Reduce Cardiovascular Morbidity and Mortality in HD Patients(EGESTUDY) |
Q64818753 | Omega 3 Fatty Acids in Patients With Chronic Renal Disease |
Q66407985 | Periodontal and Cardiovascular Diseases Project |
Q63338904 | Polypill Effects on Sub Clinical Atherosclerosis (PESCA) Trial |
Q65539922 | Predictor of Advanced Sub-Clinical Atherosclerosis (PASA) Study |
Q62031277 | The "ABCDE" Score as a Five-step Vascular Ultrasound Examination in Heart Failure |
Q65355899 | The Effect of Plant-based Diets (Vegetarian and Vegan) on Endothelial Function and Atherogenic Parameters |
Q64608316 | The Effect of Puerarin Injection on Carotid Intima-Media Thickness in Patients With Rheumatoid Arthritis |
Q65378116 | Trial of Lycopene/Ateronon for Secondary Prevention of Coronary Heart Disease |
Search more.